Intended for healthcare professionals


Harm resulting from screening is likely to be high where prevalence of breast cancer is low

BMJ 1997; 315 doi: (Published 19 July 1997) Cite this as: BMJ 1997;315:190
  1. Peymane Adab, Lecturer in public health medicinea
  1. a Department of Community Medicine, University of Hong Kong, Hong Kong

    Editor—Matti Hakama and colleagues evaluated an organised programme of screening for breast cancer in Finland.1 They report a 24% reduction in mortality from breast cancer due to screening, which, as they point out, is close to the protective effect reported in the early randomised controlled trials. In their …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription